NPC stage | LL bn (%) | SL+ SS b, n (%) | χ2c | P |
---|---|---|---|---|
Clinical | Â | Â | Â | Â |
   I | 36 (90. 0) | 2 (10. 0) | 1. 554 | 0. 21 |
   II | 334 (89. 8) | 38 (10. 2) |  |  |
   III | 212 (90. 2) | 23 (9. 8) |  |  |
   IV | 143 (93. 5) | 10 (6. 5) |  |  |
Tumor (T) | Â | Â | 3. 314 | 0. 069 |
   T1 | 151 (91. 5) | 14 (8. 5) |  |  |
   T2 | 356 (89. 9) | 40 (10. 1) |  |  |
   T3 | 139 (89. 7) | 16 (10. 3) |  |  |
   T4 | 79 (96. 3) | 3 (3. 7) |  |  |
Node(N) | Â | Â | 0. 667 | 0. 41 |
   N0 | 148 (89. 2) | 18 (10. 8) |  |  |
   N1 | 350 (91. 1) | 34 (8. 9) |  |  |
   N2 | 156 (90. 7) | 16 (9. 3) |  |  |
   N3 | 71 (93. 4) | 5 (6. 6) |  |  |
Metastasis(M) | Â | Â | 0. 000 | 1. 00 |
   M0 | 708 (90. 9) | 71 (9. 1) |  |  |
   M1 | 17 (89. 5) | 2 (10. 5) |  |  |